How Advanced Analytics is Transforming Research and Innovation in Rare Disease

Presented by

Dr. Shlomi Madar | VP Healthcare Solutions | Signals Analytics

About this talk

Rare diseases offer an interesting growth opportunity for Pharma companies who are looking to expand into new markets by leveraging their existing assets and utilizing government incentives. However, the limited number of patients and even more so a limited volume of research pose a significant challenge to obtaining and analyzing data in this space, underscoring the need for a different approach. Enter advanced data analytics and AI. Join this new webinar hosted by Dr. Shlomi Madar, VP Healthcare Solutions at Signals Analytics, as he spotlights a new capability inside Pharma Playbook. Dr. Madar will show how connected data sources via AI and machine learning can assist in building a more comprehensive and accurate ecosystem. This webinar will present a use case showing how we can surface new modalities and potential partners. Not to be missed!

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (6)
Subscribers (1200)
Signals Analytics is an advanced analytics configurable platform that extracts context from uncorrelated external data sources to uncover trends and predictive insights. Users of the platform across Pharma, Food & Beverage and Consumer Goods are data-driven and experience faster time to market, lower cost to insight and fewer product modifications post-launch when incorporating Signals Analytics’ market intelligence into their planning processes. Trusted by an impressive roster of global brands including Procter & Gamble, Nestle, Johnson & Johnson, Bayer, Roche, Mars and others, Signals Analytics is redefining the world of market intelligence. For more information visit www.signals-analytics.com.